75 / 52
75
María del Carmen Cano-García
Factores litogénicos en hombres y mujeres con litiasis urinaria recidivante
9.
Skolarikos A, Straub M, Knoll T, Sarica K, Seitz C et al.
Metabolic evaluation and recurrence prevention for urinary
stone patients: EAU Guidelines. Eur Urol. 2014. doi:10.1016/j.
eururo.2014.10.029.
10. Amaro CR, Goldberg J, Damasio PC, Leitao VA, Turney B et al.
An update on metabolic assessment in patients with urinary
lithiasis. World J Urol. 2015; 33: 125-9.
11. Maalouf N. Approach to the adult kidney stone former. Clin
Rev Bone Miner Metab. 2012; 10: 38-49.
12. Areses Trapote R, Urbieta Garagorri MA, Ubetagoyena Arrieta
M, Mingo Monge T, Arruebarrena Lizarraga D. Evaluation of
renal stone disease: metabolic study. An Pediatr (Barc). 2004;
61: 418-27.
13. Heilberg IP, Schor N. Renal stone disease: causes, evaluation
and medical treatment. Arq Bras Endocrinol Metabol. 2006;
50: 823-31.
14. Bibilash BS, Vijay A, Fazil Marickar YM. Stone composition and
metabolic status. Urol Res. 2010; 38: 211-3.
15. Parvin M, Shakhssalim N, Basiri A, Miladipour AH, Golestan B
et al. The most important metabolic risk factors in recurrent
urinary stone formers. Urol J. 2011; 8: 99-106.
16. Stitchantrakul
W,
Kochakarn
W,
Ruangraksa
C,
Domrongkitchaiporn S. Urinary risk factors for recurrent
calcium stone formation in Thai stone formers. J Med Assoc
Thai. 2007; 90: 688-98.
17. Wu W, Yang D, Tiselius HG, Ou L, Liang Y et al. The
characteristics of the stone and urine composition in Chinese
stone formers: primary report of a single-center results.
Urology. 2014; 83: 732-7.
18. Hong YH, Dublin N, Razack AH, Mohd MA, Husain R.
Urinary metabolic evaluation of stone formers-a Malaysian
perspective. Urology. 2012; 80: 529-34.
19. Rodgers A, Allie-Hamdulay S, Pinnock D, Baretta G, Trinchieri
A. Risk factors for renal calcium stone formation in South
African and European young adults. Arch Ital Urol Androl.
2009; 81: 171-4.
20. Karabacak OR, Ipek B, Ozturk U, Demirel F, Saltas H et al.
Metabolic evaluation in stone disease metabolic differences
between the pediatric and adult patients with stone disease.
Urology. 2010; 76: 238-41.
21. Strohmaier WL, Seilnacht J, Schubert G. Urinary stone formers
with hypocitraturia and normal urinary pH are at high risk for
recurrence. Urol Int. 2012; 88: 294-7.
22. Damasio PC, Amaro CR, Cunha NB, Pichutte AC, Goldberg J
et al. The role of salt abuse on risk for hypercalciuria. Nutr J.
2011; 10: 3.
23. Tang J, Chonchol MB. Vitamin D and kidney stone disease.
Curr Opin Nephrol Hypertens. 2013; 22: 383-9.
24. Pipili C, Oreopoulos DG. Vitamin D status in patients with
recurrent kidney stones. Nephron Clin Pract. 2012; 122: 134-8.